Cagrilintide, an amylin analogue, is advancing in combination with semaglutide in the Phase III CagriSema programme
At TrimBody M.D., we focus on weight loss strategies grounded in science aiming to support your overall health rather than just slimming you down
GLP-1 receptor agonists can cause gastrointestinal symptoms that doctors often dismiss as regular side effects
In a statement issued by University College London, the trials senior investigator, Thomas Foltynie, characterised the negative result as a major disappointment for patients with Parkinsons disease and for the research community
Love MI, Huber W, Anders S
For long-term storage, the gold standard is a freezer